相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
Eleni Anastasiadou et al.
CLINICAL CANCER RESEARCH (2021)
Germinotropic lymphoproliferative disorder: a systematic review
Magda Zanelli et al.
ANNALS OF HEMATOLOGY (2020)
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
Ramya Ramaswami et al.
BLOOD (2020)
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan C. Ramos et al.
BLOOD (2020)
Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics
Jouliana Sadek et al.
NATURE COMMUNICATIONS (2020)
Clinicopathologic characteristics and survival of patients with primary effusion lymphoma
Cristian Aguilar et al.
LEUKEMIA & LYMPHOMA (2020)
Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)
Kathryn Lurain et al.
BLOOD (2020)
T Cell Primary Effusion Lymphoma in an HIV-Negative Man with Liver Cirrhosis
Jacqueline Kropf et al.
AMERICAN JOURNAL OF CASE REPORTS (2020)
Viral, immunologic, and clinical features of primary effusion lymphoma
Kathryn Lurain et al.
BLOOD (2019)
Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma
Jose D. Sandoval-Sus et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Kaposi sarcoma
Ethel Cesarman et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Diagnosis and Management of Castleman Disease
Jeremy S. Abramson
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Sequential development of human herpes virus 8-positive diffuse large B-cell lymphoma and chronic myelomonocytic leukemia in a 59 year old female patient with hemoglobin SC disease
Yue Zhao et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma
Victoria A. Chang et al.
BLOOD ADVANCES (2019)
Pathology of Castleman Disease
David Wu et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
KSHV induces immunoglobulin rearrangements in mature B lymphocytes
Jennifer Totonchy et al.
PLOS PATHOGENS (2018)
Daratumumab in Primary Effusion Lymphoma
Nirav N. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Mark Manzano et al.
NATURE COMMUNICATIONS (2018)
The full spectrum of Castleman disease: 273 patients studied over 20 years
Eric Oksenhendler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies
Utthara Nayar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma
Blanca Gonzalez-Farre et al.
MODERN PATHOLOGY (2017)
PD-L1 and Notch1 expression in KSHV/HHV-8 and EBV associated germinotropic lymphoproliferative disorder: case report and review of the literature
Arash Ronaghy et al.
PATHOLOGY (2017)
Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response
A. Mularoni et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder New Findings and Review of the Literature
Tapan Bhavsar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients
Alessia Dalla Pria et al.
BLOOD (2017)
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms 2015 SH/EAHP Workshop Report-Part 3
Amy Chadburn Md et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)
Mark N. Polizzotto et al.
CLINICAL INFECTIOUS DISEASES (2016)
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R. Gopalakrishnan et al.
ONCOGENE (2016)
Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution
Stephanie Guillet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base
Adam J. Olszewski et al.
CANCER (2016)
Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy
Dirk P. Dittmer et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Multicentric Castleman disease: Where are we now?
Hao-Wei Wang et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2016)
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
S. K. Barta et al.
ANNALS OF ONCOLOGY (2015)
The tumor virus landscape of AIDS-related lymphomas
Aaron Arvey et al.
BLOOD (2015)
KSHV latent protein LANA2 inhibits sumo2 modification of p53
Marcos-Villar Laura et al.
CELL CYCLE (2015)
Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma
R. Wagener et al.
LEUKEMIA (2015)
Primary Effusion Lymphoma with Aberrant T-Cell Phenotype in an Iatrogenically Immunosuppressed Renal Transplant Male: Cytologic Diagnosis in Peritoneal Fluid
A. Kalogeraki et al.
DIAGNOSTIC CYTOPATHOLOGY (2015)
HHV-8-positive and EBV-positive Intravascular Lymphoma An Unusual Presentation of Extracavitary Primary Effusion Lymphoma
Genevieve M. Crane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy
David C. Fajgenbaum et al.
BLOOD (2014)
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease
Thomas S. Uldrick et al.
BLOOD (2014)
KSHV/HHV8-negative Effusion-based Lymphoma, a Distinct Entity Associated With Fluid Overload States
Serge Alexanian et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
Shruti Bhatt et al.
BLOOD (2013)
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
Shrub Bhatt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Extracavitary KSHV-associated Large B-Cell Lymphoma A Distinct Entity or a Subtype of Primary Effusion Lymphoma? Study of 9 Cases and Review of an Additional 43 Cases
Zeng-Gang Pan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease
Laurence Gerard et al.
BLOOD (2012)
Prognosis in primary effusion lymphoma is associated with the number of body cavities involved
Jorge J. Castillo et al.
LEUKEMIA & LYMPHOMA (2012)
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease
Christian Hoffmann et al.
BLOOD (2011)
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy
Thomas S. Uldrick et al.
BLOOD (2011)
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice
Gianna Ballon et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease
Mark Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2Rγnull Mice
Isaac W. Boss et al.
JOURNAL OF VIROLOGY (2011)
Kaposi's sarcoma associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice
Anwaar Ahmad et al.
CANCER BIOLOGY & THERAPY (2010)
An Interleukin-6-Related Systemic Inflammatory Syndrome in Patients Co-Infected with Kaposi Sarcoma-Associated Herpesvirus and HIV but without Multicentric Castleman Disease
Thomas S. Uldrick et al.
CLINICAL INFECTIOUS DISEASES (2010)
The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease
T. Powles et al.
ANNALS OF ONCOLOGY (2009)
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
Lisa S. Chen et al.
BLOOD (2009)
FLIP-mediated autophagy regulation in cell death control
Jong-Soo Lee et al.
NATURE CELL BIOLOGY (2009)
Human herpesvirus-8 (HHV-8)-Associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin
E. Boulanger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
EBV is necessary for proliferation of dually infected primary effusion lymphoma cells
Amanda A. Mack et al.
CANCER RESEARCH (2008)
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD)
A. Chadburn et al.
HISTOPATHOLOGY (2008)
The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells
Effi Wies et al.
BLOOD (2008)
Brief communication: Rituximab in HIV-associated multicentric Castleman disease
Mark Bower et al.
ANNALS OF INTERNAL MEDICINE (2007)
A viral microRNA functions as an orthologue of cellular miR-155
Eva Gottwein et al.
NATURE (2007)
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc
Jianyong Liu et al.
JOURNAL OF VIROLOGY (2007)
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-associated multicentric Castleman's disease:: ANRS 117 CastlemaB trial
Laurence Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D. Bubman et al.
ONCOGENE (2007)
Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease
Yasuhisa Abe et al.
PATHOLOGY INTERNATIONAL (2006)
A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses
A Grundhoff et al.
RNA (2006)
Fatal HHV-8-Associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma)
CF Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Constitutive NF-κB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice
P Chugh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
E Boulanger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cloning and identification of a MicroRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus
MA Samols et al.
JOURNAL OF VIROLOGY (2005)
The targeting of primary effusion lymphoma cells for apoptosi by inducing lytic replication of human herpesvirus 8 while blocking virus production
CM Klass et al.
BLOOD (2005)
HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man
SE Coupland et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells
XZ Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of microRNAs of the herpesvirus family
S Pfeffer et al.
NATURE METHODS (2005)
Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA
A Godfrey et al.
BLOOD (2005)
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
PS Eis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest
FQ An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs
C McCormick et al.
SCIENCE (2005)
Distinct cellular origins of primary effusion lymphoma with and without EBV infection
R Hamoudi et al.
LEUKEMIA RESEARCH (2004)
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma
A Chadburn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile
RG Jenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma
G Gaidano et al.
BLOOD (2003)
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts
U Klein et al.
BLOOD (2003)
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study
C Simonelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
KSHV- and EBV-associated germinotropic lymphoproliferative disorder
MQ Du et al.
BLOOD (2002)
Pyothorax-associated lymphoma -: A peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype
B Petitjean et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the IκB kinase complex
L Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
E Oksenhendler et al.
BLOOD (2002)
Kaposi sarcoma-associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders
MQ Du et al.
BLOOD (2001)
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy
L Hocqueloux et al.
AIDS (2001)
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53
C Rivas et al.
JOURNAL OF VIROLOGY (2001)
Bone marrow failure associated with human herpesvirus 8 infection after transplantation
M Luppi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells
SA Radkov et al.
NATURE MEDICINE (2000)
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease
H Katano et al.
VIROLOGY (2000)
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma
N Dupin et al.
BLOOD (2000)
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases - Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
C Parravicini et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
B Lubyova et al.
JOURNAL OF VIROLOGY (2000)
分享论文
